We read with interest the TULIP-LTE study by Vibeke Strand and colleagues1 evaluating the long-term effect of… Read More
The Lancet
Although the treatment landscape in Still’s disease has seen substantial advances in recent decades, macrophage activation syndrome… Read More
TNF inhibitors have transformed outcomes for many, but not all, people with rheumatoid arthritis. Their approval in… Read More
Polymyalgia rheumatica has long been neglected, especially when it comes to pharmaceutical development: but why? In 2025,… Read More
Autoimmune congenital heart block occurs in around 1–2% of anti-Sjögren’s syndrome-related antigen A (SSA)/Ro antibody-positive pregnancies.1 Despite… Read More